BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 28049405)

  • 1. Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance.
    Capasso C; Supuran CT
    Curr Top Med Chem; 2017; 17(11):1237-1248. PubMed ID: 28049405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview of the Selectivity and Efficiency of the Bacterial Carbonic Anhydrase Inhibitors.
    Capasso C; Supuran CT
    Curr Med Chem; 2015; 22(18):2130-9. PubMed ID: 25312213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial, fungal and protozoan carbonic anhydrases as drug targets.
    Capasso C; Supuran CT
    Expert Opin Ther Targets; 2015; 19(12):1689-704. PubMed ID: 26235676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
    Del Prete S; Vullo D; De Luca V; Carginale V; Osman SM; AlOthman Z; Supuran CT; Capasso C
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1941-6. PubMed ID: 26972117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of recombinant β-carbonic anhydrase (PgiCAb) identified in the genome of the oral pathogenic bacterium Porphyromonas gingivalis.
    Del Prete S; Vullo D; De Luca V; AlOthman Z; Osman SM; Supuran CT; Capasso C
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):366-70. PubMed ID: 25032746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How many carbonic anhydrase inhibition mechanisms exist?
    Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(3):345-60. PubMed ID: 26619898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial carbonic anhydrase inhibitors: an update on the recent literature.
    Supuran CT; Capasso C
    Expert Opin Ther Pat; 2020 Dec; 30(12):963-982. PubMed ID: 32806966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anion inhibition profiles of the γ-carbonic anhydrase from the pathogenic bacterium Burkholderia pseudomallei responsible of melioidosis and highly drug resistant to common antibiotics.
    Del Prete S; Vullo D; Di Fonzo P; Osman SM; AlOthman Z; Supuran CT; Capasso C
    Bioorg Med Chem; 2017 Jan; 25(2):575-580. PubMed ID: 27914949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomedical applications of prokaryotic carbonic anhydrases.
    Supuran CT; Capasso C
    Expert Opin Ther Pat; 2018 Oct; 28(10):745-754. PubMed ID: 29973089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrases as targets for medicinal chemistry.
    Supuran CT; Scozzafava A
    Bioorg Med Chem; 2007 Jul; 15(13):4336-50. PubMed ID: 17475500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?
    Capasso C; Supuran CT
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):325-32. PubMed ID: 24766661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Substituted Benzene-Sulfonamides and Clinically Licensed Drugs on the Catalytic Activity of CynT2, a Carbonic Anhydrase Crucial for
    Del Prete S; De Luca V; Bua S; Nocentini A; Carginale V; Supuran CT; Capasso C
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brucella suis carbonic anhydrases and their inhibitors: Towards alternative antibiotics?
    Köhler S; Ouahrani-Bettache S; Winum JY
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):683-687. PubMed ID: 28274160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anion inhibition profiles of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
    Del Prete S; Vullo D; De Luca V; Carginale V; di Fonzo P; Osman SM; AlOthman Z; Supuran CT; Capasso C
    Bioorg Med Chem; 2016 Aug; 24(16):3413-7. PubMed ID: 27283786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfonamide inhibition profiles of the β-carbonic anhydrase from the pathogenic bacterium Francisella tularensis responsible of the febrile illness tularemia.
    Del Prete S; Vullo D; Osman SM; AlOthman Z; Supuran CT; Capasso C
    Bioorg Med Chem; 2017 Jul; 25(13):3555-3561. PubMed ID: 28511911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs.
    Supuran CT
    Curr Med Chem; 2012; 19(6):831-44. PubMed ID: 22214451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and function of carbonic anhydrases.
    Supuran CT
    Biochem J; 2016 Jul; 473(14):2023-32. PubMed ID: 27407171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anion inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
    Vullo D; Del Prete S; De Luca V; Carginale V; Ferraroni M; Dedeoglu N; Osman SM; AlOthman Z; Capasso C; Supuran CT
    Bioorg Med Chem Lett; 2016 Mar; 26(5):1406-10. PubMed ID: 26853167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches.
    Annunziato G; Angeli A; D'Alba F; Bruno A; Pieroni M; Vullo D; De Luca V; Capasso C; Supuran CT; Costantino G
    ChemMedChem; 2016 Sep; 11(17):1904-14. PubMed ID: 27304878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrases--an overview.
    Supuran CT
    Curr Pharm Des; 2008; 14(7):603-14. PubMed ID: 18336305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.